US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Array Digital Infrastructure Inc.

35.86

+0.27000.76%

Post-market: 35.860.00000.00%16:10 EDT

Volume:174.97K

Turnover:6.28M

Market Cap:3.10B

PE:5.80

High:36.10

Open:35.58

Low:35.39

Close:35.59

52wk High:60.82

52wk Low:33.71

Shares:86.38M

Float Shares:15.56M

Volume Ratio:0.87

T/O Rate:1.12%

Dividend:- -

Dividend Rate:- -

EPS(TTM):6.19

EPS(LYR):0.5551

ROE:22.68%

ROA:0.02%

PB:2.45

PE(LYR):64.61

Loading ...

Overview Company News Filings

Annovis to Host Corporate Update Webinar on September 2, 2026

LEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer’s Disease

Arcutis says Health Canada approves Zoryve cream 0.05% for children with AD

Array Digital Infra Price Target Cut to $45.00/Share from $54.00 by JP Morgan

U.S. Research Roundup-Cogent Communications, Dollar Tree, Home Depot

Kuwait's Digitus Group Q2 Loss 740,230 Dinars

Press Release: Annovis Provides Corporate Updates and Second Quarter 2026 Financial Results

Press Release: Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

GMO AD Partners Outlines Q2 2026 Results, Growth Strategy and Shareholder Returns

Array Digital Infra is Maintained at Buy by Citigroup

Does Strong Interim Site-Driven Profitability and Narrowed Guidance Change The Bull Case For Array Digital (AD)?

Simply Wall St.

Press Release: Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update

Longeveron Named a Finalist Team and Will Receive a $1,000,000 Milestone 2 Award for the XPRIZE Healthspan Global Competition

Press Release: CervoMed Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

Press Release: Grey Matters Appoints Radiologist Dr. Jayson A. Lord, MD as Medical Director of Its First Dedicated PET Neuroimaging Clinic in the U.S.

Array Digital Infrastructure Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Array Digital Q2 Revenue Nearly Doubles on Site Rental Growth

Earnings Flash (AD) Array Digital Infrastructure Posts Q2 EPS $4.15

MT Newswires Live

GUIDANCE: (AD) Array Digital Infrastructure Expects 2026 Revenue Range $205M - $215M, vs. FactSet Est of $203.1M

MT Newswires Live

Array Digital Infr Q2 EPS $3.86 Beats $0.63 Estimate, Sales $54.070M Beat $52.503M Estimate

Benzinga Earnings

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/AD/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AD\",,,,,undefined,":{"symbol":"AD","market":"US","secType":"STK","nameCN":"Array Digital Infrastructure Inc.","latestPrice":35.86,"timestamp":1787688000000,"preClose":35.59,"halted":0,"volume":174969,"hourTrading":{"tag":"盘后","latestPrice":35.86,"preClose":35.86,"latestTime":"16:10 EDT","volume":584,"amount":20942.239999999998,"timestamp":1787688604732,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.007586400674346614,"floatShares":15563300,"shares":86379877,"eps":6.185934,"marketStatus":"Post-Mkt","change":0.27,"latestTime":"08-25 18:14:40 EDT","open":35.58,"high":36.1,"low":35.39,"amount":6279955,"amplitude":0.019949,"askPrice":36.57,"askSize":54,"bidPrice":35.14,"bidSize":56,"shortable":3,"etf":0,"ttmEps":6.185934,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":4,"adr":0,"exchange":"NYSE","adjPreClose":35.59,"postHourTrading":{"tag":"盘后","latestPrice":35.86,"preClose":35.86,"latestTime":"16:10 EDT","volume":584,"amount":20942.239999999998,"timestamp":1787688604732,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.872412,"impliedVol":0.2103,"impliedVolPercentile":0.136},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AD\",,,,,undefined,":{"symbol":"AD","floatShares":15563300,"roa":"0.02%","roe":"22.68%","lyrEps":0.555055,"volumeRatio":0.872412,"shares":86379877,"dividePrice":0,"high":36.1,"amplitude":0.019949,"preClose":35.59,"low":35.39,"week52Low":33.71,"pbRate":"2.45","psRate":"14.51","week52High":60.82,"institutionHeld":0.3649,"latestPrice":35.86,"committee":0.018182,"eps":6.185934,"divideRate":0,"volume":174969,"delay":0,"ttmEps":6.185934,"open":35.58,"prevYearClose":53.62,"prevWeekClose":35.66,"prevMonthClose":34.84,"prevQuarterClose":36.26,"fiveDayClose":35.05,"twentyDayClose":35,"sixtyDayClose":50.86,"dividendPayoutRate":40.52599213795753,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0.4274298457535774},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AD\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-07","symbol":"AD","fiscalQuarterEnding":"2026/06","expectedEps":0.27,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786075200000,"reportTimeType":"pre","actualEps":0.44},{"date":"2026-06-11","symbol":"AD","amount":11,"announcedDate":"2026-06-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-11","defaultRemindTime":1781184600000,"name":"Array Digital Infrastructure Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-25","payableDate":"2026-06-11","currency":"USD","dateTimestamp":1781150400000,"payDate":"2026-06-25"},{"market":"US","date":"2026-05-08","symbol":"AD","fiscalQuarterEnding":"2026/03","expectedEps":-0.06,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778212800000,"reportTimeType":"pre","actualEps":0.42},{"market":"US","date":"2026-02-20","symbol":"AD","fiscalQuarterEnding":"2025/12","expectedEps":0.32,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1771563600000,"reportTimeType":"pre","actualEps":0.48},{"date":"2026-01-23","symbol":"AD","amount":10.25,"announcedDate":"2026-01-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-23","defaultRemindTime":1769178600000,"name":"Array Digital Infrastructure Inc.","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-02","payableDate":"2026-01-23","currency":"USD","dateTimestamp":1769144400000,"payDate":"2026-02-02"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AD\",market:\"US\",,,undefined,":[{"executeDate":"2025-08-20","recordDate":"2025-08-11","paymentDate":"2025-08-19","value":23,"currency":"USD"},{"executeDate":"2026-01-23","recordDate":"2026-01-23","paymentDate":"2026-02-02","value":10.25,"currency":"USD"},{"executeDate":"2026-06-11","recordDate":"2026-06-11","paymentDate":"2026-06-25","value":11,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.2,"hold":0.6,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2,"analysts":5,"updateTime":1786593600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AD","date":"2026-08-24","current":5.797023,"percent":0.272374,"low":-273.92211,"twenty":-175.810243,"median":21.467154,"eighty":260.571771,"high":320.844562,"avg":59.893555,"sd":173.763323,"marketCap":3083841140},"quantilePoints":[{"date":"2025-08-15","current":-273.850129,"twenty":-273.893318,"median":-273.850129,"eighty":-273.612593,"marketCap":6572403103},{"date":"2025-08-22","current":-200.933798,"twenty":-273.763753,"median":-273.490226,"eighty":-228.502362,"marketCap":4822411161},{"date":"2025-08-29","current":-194.49692,"twenty":-273.591,"median":-200.933798,"eighty":-194.626488,"marketCap":4667926077},{"date":"2025-09-05","current":-189.890035,"twenty":-273.511821,"median":-195.360711,"eighty":-192.519268,"marketCap":4557360841},{"date":"2025-09-12","current":-184.671298,"twenty":-272.73443,"median":-194.119011,"eighty":-189.199003,"marketCap":4432111159},{"date":"2025-09-19","current":-175.349555,"twenty":-256.070925,"median":-192.368109,"eighty":-183.778715,"marketCap":4208389313},{"date":"2025-09-26","current":-169.950862,"twenty":-200.271577,"median":-189.74607,"eighty":-179.092649,"marketCap":4078820677},{"date":"2025-10-03","current":-180.892213,"twenty":-197.170296,"median":-184.671298,"eighty":-177.638601,"marketCap":4341413113},{"date":"2025-10-10","current":-180.028422,"twenty":-195.252737,"median":-184.059446,"eighty":-177.861746,"marketCap":4320682131},{"date":"2025-10-17","current":-179.200623,"twenty":-194.756057,"median":-183.555568,"eighty":-177.18511,"marketCap":4300814940},{"date":"2025-10-24","current":-177.581015,"twenty":-194.345757,"median":-180.586287,"eighty":-177.242697,"marketCap":4261944349},{"date":"2025-10-31","current":-176.105372,"twenty":-193.617663,"median":-180.892213,"eighty":-177.242697,"marketCap":4226528922},{"date":"2025-11-07","current":-171.642452,"twenty":-192.972746,"median":-180.010426,"eighty":-176.702827,"marketCap":4119418849},{"date":"2025-11-14","current":241.378582,"twenty":-192.09564,"median":-179.920448,"eighty":-175.407141,"marketCap":3917333000},{"date":"2025-11-21","current":240.473745,"twenty":-190.782619,"median":-179.452562,"eighty":-172.916544,"marketCap":3902648400},{"date":"2025-11-28","current":261.764027,"twenty":-189.890035,"median":-179.056658,"eighty":-170.850644,"marketCap":4248168400},{"date":"2025-12-05","current":265.117247,"twenty":-189.602105,"median":-178.588771,"eighty":240.420519,"marketCap":4302587800},{"date":"2025-12-12","current":265.543053,"twenty":-189.098227,"median":-177.958923,"eighty":244.409875,"marketCap":4309498200},{"date":"2025-12-19","current":274.059166,"twenty":-184.671298,"median":-177.329076,"eighty":249.043083,"marketCap":4447706200},{"date":"2025-12-26","current":286.620433,"twenty":-184.613712,"median":-177.149119,"eighty":260.390804,"marketCap":4651563000},{"date":"2026-01-02","current":285.396241,"twenty":-184.556126,"median":-176.681232,"eighty":261.913059,"marketCap":4631695600},{"date":"2026-01-09","current":277.199482,"twenty":-183.965869,"median":-175.78145,"eighty":263.648217,"marketCap":4498670400},{"date":"2026-01-16","current":297.372025,"twenty":-183.569965,"median":-174.161842,"eighty":266.266922,"marketCap":4826050600},{"date":"2026-01-23","current":320.844562,"twenty":-183.555568,"median":-173.981886,"eighty":271.994008,"marketCap":5206986400},{"date":"2026-01-30","current":252.1834,"twenty":-183.238845,"median":-172.02036,"eighty":268.321434,"marketCap":4092684400},{"date":"2026-02-06","current":257.665648,"twenty":-182.648588,"median":-169.950862,"eighty":267.224985,"marketCap":4181655800},{"date":"2026-02-13","current":269.109175,"twenty":-182.115917,"median":238.717297,"eighty":267.224985,"marketCap":4367372800},{"date":"2026-02-20","current":267.938209,"twenty":-181.48247,"median":240.926164,"eighty":268.704659,"marketCap":4348369200},{"date":"2026-02-27","current":255.643071,"twenty":-181.064971,"median":244.409875,"eighty":267.842403,"marketCap":4148831400},{"date":"2026-03-06","current":262.668864,"twenty":-180.769843,"median":247.365175,"eighty":267.342081,"marketCap":4262853000},{"date":"2026-03-13","current":255.643071,"twenty":-180.229973,"median":249.043083,"eighty":266.671437,"marketCap":4148831400},{"date":"2026-03-20","current":82.941723,"twenty":-180.021224,"median":248.376453,"eighty":265.819826,"marketCap":4043906649},{"date":"2026-03-27","current":82.498564,"twenty":-179.985233,"median":245.210832,"eighty":265.628214,"marketCap":4022299967},{"date":"2026-04-02","current":84.413012,"twenty":-179.95644,"median":244.199544,"eighty":265.543053,"marketCap":4115640834},{"date":"2026-04-10","current":87.513828,"twenty":-179.920448,"median":240.447132,"eighty":265.117247,"marketCap":4266824209},{"date":"2026-04-17","current":87.691125,"twenty":-179.920448,"median":236.588268,"eighty":264.265636,"marketCap":4275468504},{"date":"2026-04-24","current":86.627343,"twenty":-179.596527,"median":87.806368,"eighty":264.052733,"marketCap":4223602732},{"date":"2026-05-01","current":88.098909,"twenty":-179.308596,"median":87.655666,"eighty":263.999507,"marketCap":4295350384},{"date":"2026-05-08","current":87.40745,"twenty":-179.200623,"median":87.575882,"eighty":263.414024,"marketCap":4261637632},{"date":"2026-05-15","current":21.135166,"twenty":-178.912692,"median":87.337865,"eighty":263.147896,"marketCap":4402539647},{"date":"2026-05-22","current":21.338509,"twenty":-178.876701,"median":86.919883,"eighty":263.041444,"marketCap":4444896694},{"date":"2026-05-29","current":21.222313,"twenty":-178.646357,"median":86.396857,"eighty":262.74338,"marketCap":4420692667},{"date":"2026-06-05","current":21.55845,"twenty":-178.444805,"median":85.972934,"eighty":262.32822,"marketCap":4490711460},{"date":"2026-06-12","current":16.645033,"twenty":-178.17847,"median":85.475751,"eighty":262.157897,"marketCap":3467226884},{"date":"2026-06-18","current":16.18855,"twenty":-177.926531,"median":85.370237,"eighty":262.136607,"marketCap":3372139635},{"date":"2026-06-26","current":14.893798,"twenty":-177.667394,"median":85.086615,"eighty":261.913059,"marketCap":3102437619},{"date":"2026-07-02","current":15.151088,"twenty":-177.480239,"median":84.907561,"eighty":261.764027,"marketCap":3156032250},{"date":"2026-07-10","current":14.416565,"twenty":-177.285886,"median":83.339562,"eighty":261.593705,"marketCap":3003028221},{"date":"2026-07-17","current":14.495412,"twenty":-177.192309,"median":82.498564,"eighty":261.253061,"marketCap":3019452383},{"date":"2026-07-24","current":14.184174,"twenty":-177.005154,"median":82.259257,"eighty":261.061448,"marketCap":2954620167},{"date":"2026-07-31","current":14.516162,"twenty":-176.767611,"median":81.532476,"eighty":260.944352,"marketCap":3023774530},{"date":"2026-08-07","current":14.794201,"twenty":-176.56606,"median":80.513209,"eighty":260.8379,"marketCap":3081691310},{"date":"2026-08-14","current":5.765224,"twenty":-176.069381,"median":21.824041,"eighty":260.742094,"marketCap":3087300300},{"date":"2026-08-21","current":5.739385,"twenty":-175.867829,"median":21.55845,"eighty":260.635642,"marketCap":3073463660},{"date":"2026-08-24","current":5.758764,"twenty":-175.810243,"median":21.467154,"eighty":260.571771,"marketCap":3083841140}],"updateTime":1787693235089},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AD\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662509732","title":"Annovis to Host Corporate Update Webinar on September 2, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662509732","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662509732?lang=en_us&edition=fundamental","pubTime":"2026-08-25 20:00","pubTimestamp":1787659200,"startTime":"0","endTime":"0","summary":"MALVERN, Pa., Aug.  25, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/25/3350406/0/en/annovis-to-host-corporate-update-webinar-on-september-2-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ANVS","BK4588","BK4132","LU1169589451.USD","LU1169590202.USD","HST","AD","BK4218","BK4181","BK4585","PD","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661327966","title":"LEQEMBI IQLIK® (lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2661327966","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661327966?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:04","pubTimestamp":1787573040,"startTime":"0","endTime":"0","summary":"LEQEMBI IQLIK is the first-of-its-kind anti-amyloid treatment worldwide offering at-home dosing for initiation and maintenance (approved in the U.S.)TOKYO and CAMBRIDGE, Mass., Aug.  24, 2026 (GLOBE N","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/24/3349698/0/en/leqembi-iqlik-lecanemab-irmb-autoinjector-for-initiation-of-therapy-now-available-in-the-u-s-for-early-alzheimer-s-disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4132","MCI","BK4080","AD","CDR","CAA","ARIA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661940239","title":"Arcutis says Health Canada approves Zoryve cream 0.05% for children with AD","url":"https://stock-news.laohu8.com/highlight/detail?id=2661940239","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661940239?lang=en_us&edition=fundamental","pubTime":"2026-08-21 01:30","pubTimestamp":1787247037,"startTime":"0","endTime":"0","summary":"Arcutis Canada announced that Health Canada has approved ZORYVE cream 0.05% for the topical treatment of mild to moderate atopic dermatitis in pedi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/arcutis-says-health-canada-approves-zoryve-cream-0-05-for-children-with-ad-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/arcutis-says-health-canada-approves-zoryve-cream-0-05-for-children-with-ad-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AD","BK4132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660044420","title":"Array Digital Infra Price Target Cut to $45.00/Share from $54.00 by JP Morgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2660044420","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660044420?lang=en_us&edition=fundamental","pubTime":"2026-08-20 03:12","pubTimestamp":1787166720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AD/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AD","BK4132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660438984","title":"U.S. Research Roundup-Cogent Communications, Dollar Tree, Home Depot","url":"https://stock-news.laohu8.com/highlight/detail?id=2660438984","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660438984?lang=en_us&edition=fundamental","pubTime":"2026-08-19 15:50","pubTimestamp":1787125815,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Cogent Communications, Dollar Tree, Home DepotAug 19 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nL4N44G0KE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SEPN","WDGF","HOMZ","ZAP","FSPC","EVX","CGW","IDEF","MD","GPN","TBLU","HONA","KROP","COR","ELF","PKB","FOWF","RSPS","MCK","RTH","CCOI","TRUM","MRCY","BZZ","HWAY","AMLX","KEYS","SPSC","NUKX","DE","TDS","DLTR","CAH","D","BPAY","BAND","MADE","ONCY","VEGI","SJM","HD","NOC","HSIC","ARMK","AD","ECL","FTAG","AGCO","SHLD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659171711","title":"Kuwait's Digitus Group Q2 Loss 740,230 Dinars","url":"https://stock-news.laohu8.com/highlight/detail?id=2659171711","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659171711?lang=en_us&edition=fundamental","pubTime":"2026-08-16 14:06","pubTimestamp":1786860366,"startTime":"0","endTime":"0","summary":"Aug 16 (Reuters) - DIGITUS GROUP FOR DIGITAL INFRASTRUCTURE, DATA CENTERS & COMMUNICATIONS::*DIGITUS GROUP Q2 NET LOSS ATTRIBUTABLE 740,230 DINARS*DIGITUS GROUP Q2 TOTAL OPERATING REVENUE 6.9 MILLION ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260816:nRSD1zTVcD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AD","TDS","BK4132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659099146","title":"Press Release: Annovis Provides Corporate Updates and Second Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2659099146","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659099146?lang=en_us&edition=fundamental","pubTime":"2026-08-14 20:01","pubTimestamp":1786708860,"startTime":"0","endTime":"0","summary":"-- Pivotal Phase 3 Alzheimer's disease  trial is fully enrolled with a. total number of 850 patients, exceeding original projections.-- Parkinson's disease  open-label extension  study has enrolled. 266 patients with full enrollment projected in Q4 2026.-- Annovis will host a corporate update webinar on Wednesday, September 2,-- Patients: The pivotal Phase 3 AD trial includes patients diagnosed with. early AD  who are also positive for plasma pTau217 biomarker,confirming the presence of amyloid and tau pathology in the brain.-- Study design: The study measures cognition  and function. pTau217, and other biomarkers to evaluate changes in disease pathology.The study is designed to test both symptomatic  and. -- Timeline: The Company plans a database lock for the 6-month analysis in. Q1 2027, with the top-line symptomatic data readout anticipated in the. same quarter. The disease-modifying data readout is expected a year. later.Alzheimer's disease -- OLE study-- Start: The AD OLE study is","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AD","BK4132","ANVS","BK4139","LU1169589451.USD","PD","DBS","BK4023","LU1169590202.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659145881","title":"Press Release: Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659145881","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659145881?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:00","pubTimestamp":1786705200,"startTime":"0","endTime":"0","summary":"president and chief executive officer and a member of the Board of. Directors. Co-founder Paul L. Berns, will serve as Executive Chair.-- Dr. Pinto has made significant contributions to Neumora since. joining in 2021, having served in roles of increasing","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NMRA","AD","BK4132","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659116374","title":"GMO AD Partners Outlines Q2 2026 Results, Growth Strategy and Shareholder Returns","url":"https://stock-news.laohu8.com/highlight/detail?id=2659116374","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659116374?lang=en_us&edition=fundamental","pubTime":"2026-08-14 14:59","pubTimestamp":1786690743,"startTime":"0","endTime":"0","summary":"The latest update is out from GMO AD Partners Inc. ( ($JP:4784) ). GMO AD Partners Inc., under the GMO Internet umbrella, reported its financial re...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gmo-ad-partners-outlines-q2-2026-results-growth-strategy-and-shareholder-returns?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gmo-ad-partners-outlines-q2-2026-results-growth-strategy-and-shareholder-returns?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AD","BK4132","GMO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659674241","title":"Array Digital Infra is Maintained at Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2659674241","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659674241?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:26","pubTimestamp":1786652760,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AD/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AD","BK4132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659133656","title":"Does Strong Interim Site-Driven Profitability and Narrowed Guidance Change The Bull Case For Array Digital (AD)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2659133656","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659133656?lang=en_us&edition=fundamental","pubTime":"2026-08-13 12:53","pubTimestamp":1786596837,"startTime":"0","endTime":"0","summary":"In August 2026, Array Digital Infrastructure, Inc. reported second-quarter revenue of US$54.07 million and net income of US$358.7 million, while narrowing its full-year 2026 revenue guidance to US$205 million–US$215 million on higher interim site revenue.\nThe sharp uplift in profitability and tighter guidance range suggest that interim site performance is having a material impact on the company’s earnings profile and visibility.\nWe’ll now consider how this stronger interim site-driven...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9031000-choice1-main-header/1585186715767","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9031000-choice1-main-header/1585186715767"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/telecom/nyse-ad/array-digital-infrastructure/news/does-strong-interim-site-driven-profitability-and-narrowed-g","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/telecom/nyse-ad/array-digital-infrastructure/news/does-strong-interim-site-driven-profitability-and-narrowed-g","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["RGLO","VOTE","VGFPF","DECU","JOYT","PMDE","GXDW","FEBU","DTCR","BK4132","AD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907259","title":"Press Release: Longeveron Announces 2026 Second Quarter Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907259","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907259?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:05","pubTimestamp":1786565100,"startTime":"0","endTime":"0","summary":"-- On track for September 2026 top-line results from Phase 2b clinical trial.  evaluating laromestrocel as a potential adjunct treatment for. hypoplastic left heart syndrome , a rare pediatric disease and. -- Longeveron selected as a Finalist and Milestone 2 Awardee for the XPRIZE. Healthspan competition based on published clinical trial results which. indicated laromestrocel increased 6-minute walk distance in patients with. -- Three new independent Directors join Longeveron's Board of Directors. laromestrocel as a potential adjunct therapy for HLHS are anticipated in. -- In May, the Company announced that the U.S. Food and Drug Administration.  held a Type C meeting in late March 2026 focused on the ELPIS II. Phase 2b clinical trial and upcoming data readout.-- Also in May, the Company announced that the independent Data Monitoring. Committee  completed its final prespecified data review for ELPIS II. Phase 2b clinical trial . The DMC performed a risk-benefit. assessment, indicated n","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4189","IND","R","BK4022","LGVN","BK4139","GDOC","HYLG","MEDX","BK4081","BK4132","EMA","NVIB","BK4232","IDNA","DMC","AD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658194913","title":"Longeveron Named a Finalist Team and Will Receive a $1,000,000 Milestone 2 Award for the XPRIZE Healthspan Global Competition","url":"https://stock-news.laohu8.com/highlight/detail?id=2658194913","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658194913?lang=en_us&edition=fundamental","pubTime":"2026-08-11 21:05","pubTimestamp":1786453500,"startTime":"0","endTime":"0","summary":"Joshua Hare, MD, FACC, FAHA, Co-Founder, Chief Science Officer and Executive Chairman, Longeveron","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/11/3342811/0/en/longeveron-named-a-finalist-team-and-will-receive-a-1-000-000-milestone-2-award-for-the-xprize-healthspan-global-competition.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGVN","NVIB","IDNA","BK4132","BK4120","MSC","BK4150","BK4575","MEDX","AD","GDOC","BK4139","TISI","HYLG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658933484","title":"Press Release: CervoMed Reports Second Quarter 2026 Financial Results and Provides Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2658933484","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658933484?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:30","pubTimestamp":1786361400,"startTime":"0","endTime":"0","summary":"partnership to advance its neflamapimod program into a Phase 3 clinical. -- CervoMed received a notice of allowance from the U.S. Patent and. Trademark Office in June 2026 for a new patent covering the use of","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0240878834.USD","BK4097","LU0205194284.USD","LU0345774391.USD","LU0205193047.USD","LU0345774631.USD","AAIC","LU0240877869.USD","CRVO","AD","BK4139","DLB","BK4132","LU0348723411.USD","BK4110"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658980724","title":"Press Release: Grey Matters Appoints Radiologist Dr. Jayson A. Lord, MD as Medical Director of Its First Dedicated PET Neuroimaging Clinic in the U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2658980724","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658980724?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:00","pubTimestamp":1786359600,"startTime":"0","endTime":"0","summary":"VANCOUVER, British Columbia, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Grey Matters Health Inc. (the \"Company\" or \"Grey Matters\") (CSE: GREY) (FRANKFURT: AGW0) (OTC: AGNPF), a Canadian healthcare company, is ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","BK4604","MD","TM","BK4132","AD","BK4585","BK4196","BK4099","BK4555","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657444586","title":"Array Digital Infrastructure Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657444586","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657444586?lang=en_us&edition=fundamental","pubTime":"2026-08-07 22:31","pubTimestamp":1786113108,"startTime":"0","endTime":"0","summary":"Array Digital Infrastructure Inc reports results for the quarter ended June 30 - Earnings SummaryArray Digital Infrastructure IncAD.Nreported quarterly adjusted earnings of $4.15 per share for the qua","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N4441OM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4132","AD","TDS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657648260","title":"Array Digital Q2 Revenue Nearly Doubles on Site Rental Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2657648260","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657648260?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:42","pubTimestamp":1786102956,"startTime":"0","endTime":"0","summary":"Array Digital Q2 revenue nearly doubles on site rental growthOverviewUS wireless tower operator's Q2 revenue nearly doubled, driven by 95% growth in site rentalsNet income and diluted EPS from continu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL1N4440ED:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","LU2249611893.SGD","LU2357125470.USD","BK4132","LU0823414551.USD","BK4160","BK4585","LU1983299162.USD","LU2294711713.HKD","LU1093756168.USD","LU0823414478.USD","BK4588","TDS","BK4205","BK4096","BK4135","LU2506951792.HKD","ARRY","BK4233","DBRG","AD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657118648","title":"Earnings Flash (AD) Array Digital Infrastructure Posts Q2 EPS $4.15","url":"https://stock-news.laohu8.com/highlight/detail?id=2657118648","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657118648?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:38","pubTimestamp":1786102721,"startTime":"0","endTime":"0","summary":"Earnings Flash (AD) Array Digital Infrastructure Posts Q2 EPS $4.15","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DTCR","AD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657364811","title":"GUIDANCE: (AD) Array Digital Infrastructure Expects 2026 Revenue Range $205M - $215M, vs. FactSet Est of $203.1M","url":"https://stock-news.laohu8.com/highlight/detail?id=2657364811","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657364811?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:38","pubTimestamp":1786102704,"startTime":"0","endTime":"0","summary":"GUIDANCE: (AD) Array Digital Infrastructure Expects 2026 Revenue Range $205M - $215M, vs. FactSet Est of $203.1M","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DTCR","AD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657648285","title":"Array Digital Infr Q2 EPS $3.86 Beats $0.63 Estimate, Sales $54.070M Beat $52.503M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657648285","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657648285?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:37","pubTimestamp":1786102665,"startTime":"0","endTime":"0","summary":"Array Digital Infr (NYSE:AD) reported quarterly earnings of $3.86 per share which beat the analyst consensus estimate of $0.63 by 512.7 percent. This is a 972.22 percent increase over earnings of $0.36 per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61034544/array-digital-infr-q2-eps-3-86-beats-0-63-estimate-sales-54-070m-beat-52-503m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4132","AD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}]}}